Skip to main content
SpringerLink
Log in
Book cover

Cardiovascular Drug Therapy in the Elderly pp 80–103Cite as

Nifedipine

  • Chapter

  • 82 Accesses

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 72))

Abstract

Nifedipine, one of the most commonly used calcium antagonists and the most commonly used dihydropyridine derivative, is used for treatment of hypertension, angina pectoris, hypertrophic cardiomyopathy, and peripheral vascular disease, and has been investigated for treatment of congestive heart failure and for secondary prevention in postmyocardial infarction. The major disadvantage of nifedipine is the fact that it accelerates heart rate secondary to potent peripheral vasodilation.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fleckenstein A, et al: BAY a 1040: ein hochaktiver Ca++-antagonistischer inhibitor des elektromechanischen Koppelungsprozess in Warmbluten Myokard. Arzneimittelforsch 22:22, 1972.

    PubMed  CAS  Google Scholar 

  2. Raff KH, et al: Untersuchungen mit Nifedipine, einer coronargefasserweiterenden Substanz mit schneller sublingualer Wirkung. Arzneimittelforsch 22:33, 1972.

    PubMed  CAS  Google Scholar 

  3. Hugenholtz PG, et al: Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. Am J Cardiol 47:163, 1981.

    Article  PubMed  CAS  Google Scholar 

  4. Verdouw PD, et al: Effect of nifedipine on segmental myocardial function in the anesthetized pig. Eur J Pharmacol 63:209, 1980.

    Article  PubMed  CAS  Google Scholar 

  5. Abrahamsson T, Sjöquist PO: Intracoronary nifedipine depresses left ventricular regional function more in ischemic than in non-ischemic myocardium. AHA 1983.

    Google Scholar 

  6. Serruys PW, et al: Regional wall motion from radiopaque markers after intravenous and intracoronary injections of nifedepine. Circulation 63:584, 1981.

    Article  PubMed  CAS  Google Scholar 

  7. Lichtlen P, et al: Mechanism of various antianginal drugs: relationship between regional flow behaviour and contractility. In: Jatene AD, Lichtlen PR (eds) New therapy of ischemic heart disease. Excerpta Medica, Amsterdam, 1976, p 14.

    Google Scholar 

  8. Van den Brand M, et al: Changes in left and right ventricular haemodynamics in angina pectoris patients following adalat administration. In: Jatene AD, Lichtlen PR (eds) New therapy of ischemic heart disease. Excerpta Medica, Amsterdam, 1976, p 69.

    Google Scholar 

  9. Zacca NM, et al: Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina. Am J Cardiol 50:689, 1982.

    Article  PubMed  CAS  Google Scholar 

  10. Rousseau MF, et al: Impaired early left ventricular relaxation in coronary artery disease: effects of intracoronary nifedipine. Circulation 62:764, 1980.

    PubMed  CAS  Google Scholar 

  11. Ludbrook PA, et al: Influence of right ventricular hemodynamics on left ventricular diastolic pressure-volume relations in man. Circulation 59:21, 1979.

    PubMed  CAS  Google Scholar 

  12. Schulz W, et al: Der Einfluss von intrakoronarem und intravenosem Nifedipine und die allgemeine und lokale Gtassweite von epikardialen Koronararterien bei stabiler Angina pectoris: ein antianginoser Wirkaspekt? Z Kardiol 70:809, 1982.

    Google Scholar 

  13. Rafflenbeul W, Lichtlen PR: Release of residual vascular tone in coronary artery stenoses with nifedipine and glyceryl trinitrate. In: Kaltenbach M, Neufeld HN (eds) New therapy of ischaemic heart disease and hypertension: 5th international adalat symposium. Excerpta Medica, Amsterdam, 1983, p 300.

    Google Scholar 

  14. Feldman RL, et al: Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease. Am Heart J 105:651, 1983.

    Article  PubMed  CAS  Google Scholar 

  15. Rich S, et al: The angiographic effect of ergonovine and nifedipine in coronary artery spasm. Circulation 62:1127, 1980.

    PubMed  CAS  Google Scholar 

  16. Emanuelsson H, Holmberg S: Mechanisms of angina relief after nifedipine: a hemodynamic and myocardial metabolic study. Circulation 68:124, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Stone DL, et al: Coronary haemodynamic effects of nifedipine: comparison with glyceryl trinitrate. Br Heart J 49:442, 1983.

    Article  PubMed  CAS  Google Scholar 

  18. Sirnes A, et al: Nifedipine in acute myocardial infarction: no influence on enzymatic infarct size. AHA, 1983.

    Google Scholar 

  19. Ekelund LG, Oro L: Antianginal efficiency of nifedipine with and without a beta-blocker, studied with exercise test: a double blind-randomized subacute study. Clin Cardiol 2:203, 1979.

    PubMed  CAS  Google Scholar 

  20. Ekelund LG, et al: Effect of nifedipine on exercise tolerance in patients with angina pectoris. In: Hashimoto K, Kinura E, Kobayarski T, (eds) New therapy of ischemic heart disease: proceedings of the first international adalat symposium. University of Tokyo Press, Tokyo, 1973, p. 144.

    Google Scholar 

  21. Sherman L, Liang CS: Nifedipine in chronic stable angina: a double-blind placebo-controlled crossover trial. Am J Cardiol 51:706, 1983.

    Article  PubMed  CAS  Google Scholar 

  22. Novo S, et al: Nifedipine. An abstract submitted to the symposium on cardiovascular pharmacotherapy, Geneva, 1985.

    Google Scholar 

  23. Bertrand ME, et al: Treatment of spasm of the coronary artery with nifedipine. Eur Heart J [Supp1 B] 1:65, 1980.

    CAS  Google Scholar 

  24. Hugenholtz PG, et al: Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia. Am J Cardiol 47:163, 1981.

    Article  PubMed  CAS  Google Scholar 

  25. Antman E, et al: Nifedipine therapy for coronary artery spasm. N Engl J Med 302:1269, 1980.

    Article  PubMed  CAS  Google Scholar 

  26. Hill SA, et al: Randomized double-blind comparison of nifedipine and isosorbide dinitrate in patients with coronary arterial spasm. Am J Cardiol 49:431, 1982.

    Article  PubMed  CAS  Google Scholar 

  27. Hill JA, et al: Long-term responses to nifedipine in patients with coronary spasm who have an initial favorable response. Am J Cardiol 52:26, 1983.

    Article  PubMed  CAS  Google Scholar 

  28. Ricci DR, et al: Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiograms. Am J Cardiol 43:1073, 1979.

    Article  PubMed  CAS  Google Scholar 

  29. Dangman KH, Hoffman BF: Effects of nifedipine on electrical activity of cardiac cells. Am J Cardiol 46:1059, 1980.

    Article  PubMed  CAS  Google Scholar 

  30. Bourmayan C, et al: Prinzmetal’s variant angina unresponsive to calcium channel-blocking drugs but responsive to combined calcium channel- and beta-blocking drugs. Circulation 68:1792, 1983.

    Google Scholar 

  31. Blaustein AS, et al: Adjunctive nifedipine therapy in high-risk, medically refractory, unstable angina pectoris. Am J Cardiol 52:950, 1983.

    Article  PubMed  CAS  Google Scholar 

  32. Theroux P, et al: Provocative testing with ergonovine to evaluate the efficacy of treatment with calcium antagonists in variant angina. Circulation 60:504, 1979.

    PubMed  CAS  Google Scholar 

  33. Johnson SM, et al: Effects of verapamil and nifedipine on left ventricular function with Prinzmetal’s variant angina pectoris. Am J Cardiol:1289, 1981.

    Google Scholar 

  34. Waters DD, et al: Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine, diltiazem and verapamil in variant aging. Am J Cardiol 48:123, 1981.

    Article  PubMed  CAS  Google Scholar 

  35. Lund-Johansen P, Omvik P: Haemodynamic effects of nifedipine in essential hypertension at rest and during exercise. J Hypertension 1:159, 1983.

    Article  CAS  Google Scholar 

  36. Olivari MT, et al: Treatment of hypertension with nifedipine, a calcium antagonistic agent. Circulation 59:1056, 1979.

    PubMed  CAS  Google Scholar 

  37. Hiramatsu K, et al: Acute effects of the calcium antagonist, nifedipine, on blood pressure, pulse rate, and the renin-angiotensin aldosterone system in patients with essential hypertension. Am Heart J 104:146, 1982.

    Article  Google Scholar 

  38. Millar JA, et al: Calcium antagonists decrease adrenal and vascular responsiveness to angiotensin II in normal man. Clin Sci 61:655, 1981.

    Google Scholar 

  39. MacGregor GA: Discussion. In: Kaltenbach M, Neufeld HN (eds) New therapy of ischaemic heart disease and hypertension: 5th international adalat symposium. Excerpta Medica, Amsterdam, 1983, p 156.

    Google Scholar 

  40. Thibonnier M, et al: Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension. Eur J Clin Pharmacol 17:161, 1980.

    Article  PubMed  CAS  Google Scholar 

  41. Landmark K, Dale J: Antihypertensive, haemodynamic and metabolic effects of nifedipine slow-release tablets in elderly patients. Acta Med Scand 218:389, 1985.

    Article  PubMed  CAS  Google Scholar 

  42. Stessman J, et al: Nifedipine in the treatment of hypertension in the elderly. J Clin Pharma¬col 25:193, 1985.

    CAS  Google Scholar 

  43. Opie LH, White JD: Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism atenolol. Am Heart J 104:606, 1982.

    Article  PubMed  CAS  Google Scholar 

  44. Bertel O, et al: Nifedipine in hypertensive emergencies. Br Med J 286:19, 1983.

    Article  CAS  Google Scholar 

  45. Bertel O, et al: Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension 2:130, 1980.

    PubMed  CAS  Google Scholar 

  46. Christensen CK, et al: Renal effects of acute calcium blockade with nifedipine in hypertensive patients receiving beta-adrenoreceptor-blocking drugs. Clin Pharmacol Ther 32:572, 1982.

    Article  PubMed  CAS  Google Scholar 

  47. Simmonneau G, et al: Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 304:1582, 1981.

    Article  Google Scholar 

  48. Camerini F, et al: Primary pulmonary hypertension effects of a calcium antagonist drug (nifedipine). Br Heart J 44:352, 1980.

    Article  PubMed  CAS  Google Scholar 

  49. Klugmann S, et al: Acute hemodynamic effects of nifedipine in pulmonary hypertension. Circulation [Suppl 3] 62:503, 1980.

    Google Scholar 

  50. Rich S, et al: The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. Circulation 71:1191, 1985.

    Article  PubMed  CAS  Google Scholar 

  51. Landmark K, et al: Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy. Br Heart J 48:19, 1982.

    Article  PubMed  CAS  Google Scholar 

  52. Lowell BH, et al: Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy. Circulation 65:499, 1982.

    Article  Google Scholar 

  53. Paulus WJ, et al: Altered left ventricular diastolic properties during pacing-induced ischemia in dogs with coronary stenoses: potentiation by caffeine. Circ Res 50:218, 1982.

    PubMed  CAS  Google Scholar 

  54. Paulus WJ, et al: Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation? J Am Coll Cardiol 2:879, 1983.

    Article  PubMed  CAS  Google Scholar 

  55. Katz RI: Failure of low dose nifedipine to improve exercise tolerance in stable angina. Am J Cardiol 49:142, 1982.

    Article  Google Scholar 

  56. Elkayam U, et al: Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure. Am J Cardiol 52:1041, 1983.

    Article  PubMed  CAS  Google Scholar 

  57. Lundbrook PA, et al: Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation 65:489, 1982.

    Article  Google Scholar 

  58. Klugmann S, et al: Haemodynamic effects of nifedipine in heart failure. Br Heart J 43:440, 1980.

    Article  PubMed  CAS  Google Scholar 

  59. Gourgon R, et al: Effects of nifedipine on the load conditions and inotropism of the left ventricle in subjects suffering from nonocclusive primary cardiomyopathy. In: Puech P, Krebs R (eds) New therapy of ischemic heart disease: 4th international adalat symposium. Excerpta Medica, Amsterdam, 1980, p 268.

    Google Scholar 

  60. Moret discussion: In: Kaltenbach M, Newfeld (eds) New therapy of ischaemic heart disease and hypertension: 5th international adalat symposium. Excerpta Medica, Amsterdam, 1983, p 79.

    Google Scholar 

  61. Matsumoto S, et al: Hemodynamic effects of nifedipine in congestive heart failure. Am J Cardiol 46:476, 1980.

    Article  PubMed  CAS  Google Scholar 

  62. Cantelli I, et al: Acute hemodynamic effects of combined therapy with digoxin and nifedi¬pine in patients with chronic heart failure. Am Heart J 106:308, 1983.

    Article  PubMed  CAS  Google Scholar 

  63. Polese A, et al: Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. Am J Med 66:825, 1979.

    Article  PubMed  CAS  Google Scholar 

  64. Gottlieb SO, et al: Acute nifedipine withdrawal: consequences of preoperative and late cessation of therapy in patients with prior unstable angina. J Am Coll Cardiol 4:382, 1984.

    Article  PubMed  CAS  Google Scholar 

  65. Ebner F, Dunschede HB: Haemodynamics, therapeutic mechanism of action and clinical findings of adalat use based on worldwide clinical trials. In: Jatene AD, Lichtlen PR (eds) The third international adalat symposium. Excerpta Medica, Amsterdam, 1976, p 283.

    Google Scholar 

  66. Subramanian VB, et al: Rationale for the choice of calcium antagonists in chronic stable angina: an objective double-blind placebo-controlled comparison of nifedipine and verapamil. Am J Cardiol 50:1173, 1982.

    Article  PubMed  CAS  Google Scholar 

  67. Schanzenbächer P, et al: Paradoxical angina after nifedipine: angiographic documentation. Am J Cardiol 53:345, 1984.

    Article  PubMed  Google Scholar 

  68. Ebner F, et al: Wisksamkeit und Vertraglichkeit von Adalat (BAY a 1040, Nifedipine) bei Langzeitapplikation an Patienten mit koronarer Herzkrankheit. Therapiewoche 25:37, 1975.

    Google Scholar 

  69. Pedersen KE, et al: Effect of nifedipine on digoxin kinetics in healthy subjects. Clin Pharmacol Ther 32:562, 1982.

    Article  PubMed  CAS  Google Scholar 

  70. Beiz GG, et al: Digoxin plasma concentrations and nifedipine. Lancet 1:844, 1981.

    Google Scholar 

  71. Belz GG, et al: Interaction between digoxin and calcium antagonists and arrhythmic drugs. Clin Pharmacol Ther 33:410, 1983.

    Article  CAS  Google Scholar 

  72. Sakai M, et al: Comparison of the effect of nifedipine and diltiazem on serum digoxin concentration: a crossover study. Proc Annu Meet Jpn Circ J 47:877, 1983.

    Google Scholar 

  73. Schwartz JB, et al: The effect of nifedipine on serum digoxin concentrations in patients. Am Heart J 107:669, 1984.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Geriatric Cardiology Research Foundation, Tel-Aviv, Israel

    Adam Schneeweiss M.D.

  2. Department of Medicine, University of Heidelberg, Germany

    Gotthard Schettler M.D.

Authors
  1. Adam Schneeweiss M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gotthard Schettler M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Schneeweiss, A., Schettler, G. (1988). Nifedipine. In: Cardiovascular Drug Therapy in the Elderly. Developments in Cardiovascular Medicine, vol 72. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2063-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2063-0_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9225-8

  • Online ISBN: 978-1-4613-2063-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation